Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weigel, T. L.
Right arrow Articles by Luketich, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weigel, T. L.
Right arrow Articles by Luketich, J. D.
Related Collections
Right arrow Other Thoracic

Annals of Surgical Oncology, Vol 7, Issue 3 176-180, Copyright © 2000 by Society of Surgical Oncology


ARTICLES

Fluorescence bronchoscopic surveillance after curative surgical resection for non-small-cell lung cancer

T. L. Weigel, S. Yousem, S. Dacic, P. J. Kosco, J. Siegfried and J. D. Luketich
Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

BACKGROUND: Second lung primaries occur at a rate of up to 3% per patient-year after curative resection for non-small-cell lung carcinoma. Postresection patients are often poor candidates for further curative surgery because of their diminished pulmonary reserve. The aim of this study was to evaluate the role of fluorescence bronchoscopy by using the Xillix LIFE-Lung Fluorescence Endoscopy System to identify second lung primaries in patients who have had a previous curative resection of a non-small-cell lung cancer. METHODS: Patients who had no evidence of disease status after resection of a non-small-cell lung cancer were identified from a prospectively collected data base and entered onto a fluorescence bronchoscopy surveillance protocol. All suspicious areas, as well as several areas of apparently normal mucosa, were sampled for biopsy. A single pathologist reviewed all biopsy specimens, with 10% of biopsies re-reviewed, for quality control, by a second pulmonary pathologist. RESULTS: A total of 31 surveillance fluorescence bronchoscopies were performed on 25 patients after conventional bronchoscopy. Four intraepithelial neoplasias or invasive carcinomas were identified in 3 (12%) of 25 patients screened. The addition of the LIFE examination to conventional bronchoscopy increased the sensitivity of screening from 25.0% to 75.0%, which yielded a relative sensitivity of 300% with a negative predictive value of .97. CONCLUSIONS: Use of postresection surveillance with fluorescence bronchoscopy identified intraepithelial or invasive lesions in 12% of non-small-cell lung cancer patients, and the system was three times more sensitive than conventional bronchoscopy to identify these early mucosal lesions. Fluorescence bronchoscopic surveillance of this high-risk, postresection population will help better define the true rate of occurrence and the natural history of second primaries and may assist in monitoring their response to newer, noninvasive treatment methods, such as photodynamic therapy or chemopreventive agents, in future trials.


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
S. Lam, B. Standish, C. Baldwin, A. McWilliams, J. leRiche, A. Gazdar, A. I. Vitkin, V. Yang, N. Ikeda, and C. MacAulay
In vivo Optical Coherence Tomography Imaging of Preinvasive Bronchial Lesions
Clin. Cancer Res., April 1, 2008; 14(7): 2006 - 2011.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
T. C. Kennedy, A. McWilliams, E. Edell, T. Sutedja, G. Downie, R. Yung, A. Gazdar, and P. N. Mathur
Bronchial Intraepithelial Neoplasia/Early Central Airways Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 221S - 233S.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. Rubins, M. Unger, and G. L. Colice
Follow-up and Surveillance of the Lung Cancer Patient Following Curative Intent Therapy: ACCP Evidence-Based Clinical Practice Guideline (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 355S - 367S.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. Feller-Kopman, W. Lunn, and A. Ernst
Autofluorescence Bronchoscopy and Endobronchial Ultrasound: A Practical Review
Ann. Thorac. Surg., December 1, 2005; 80(6): 2395 - 2401.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
G. Loewen, M. Reid, D. Tan, D. Klippenstein, E. Nava, R. Natarajan, and M. Mahoney
Bimodality Lung Cancer Screening in High-Risk Patients: A Preliminary Report
Chest, May 1, 2004; 125(5_suppl): 163S - 164S.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Means-Markwell, R. I. Linnoila, J. Williams, P. A. Janne, F. Kaye, K. O'Neil, and B. E. Johnson
Prospective Study of the Airways and Pulmonary Parenchyma of Patients at Risk for a Second Lung Cancer
Clin. Cancer Res., December 1, 2003; 9(16): 5915 - 5921.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. Ernst, G. A. Silvestri, and D. Johnstone
Interventional Pulmonary Procedures: Guidelines from the American College of Chest Physicians
Chest, May 1, 2003; 123(5): 1693 - 1717.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Society of Surgical Oncology.